n.v.

Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Update with KOL SpeakersVivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Update with KOL Speakers

Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Update with KOL Speakers

Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Update with KOL Speakers Halle (Saale) / Munich, Germany, February 19, 2025…

1 month ago
Vivoryon Therapeutics N.V. Provides R&D-Update Further Strengthening Development Pipeline in Kidney DiseaseVivoryon Therapeutics N.V. Provides R&D-Update Further Strengthening Development Pipeline in Kidney Disease

Vivoryon Therapeutics N.V. Provides R&D-Update Further Strengthening Development Pipeline in Kidney Disease

Vivoryon Therapeutics N.V. Provides R&D-Update Further Strengthening Development Pipeline in Kidney Disease A meta-analysis of VIVIAD and VIVA-MIND1 data confirmed…

3 months ago